Page last updated: 2024-09-03

przewaquinone d and Atherosclerosis

przewaquinone d has been researched along with Atherosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
An, L; Chen, J; Hu, X; Li, P; Li, X; Peng, L; Sun, N; Xu, Y; Yang, Y; Zhou, P	1

Other Studies

1 other study(ies) available for przewaquinone d and Atherosclerosis

Article	Year
Tanshindiol C inhibits oxidized low-density lipoprotein induced macrophage foam cell formation via a peroxiredoxin 1 dependent pathway. Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:3 Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; Cells, Cultured; Diterpenes; Drugs, Chinese Herbal; Foam Cells; HEK293 Cells; Humans; Lipoproteins, LDL; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Peroxiredoxins; Salvia miltiorrhiza; Signal Transduction	2018

Article

Year

Tanshindiol C inhibits oxidized low-density lipoprotein induced macrophage foam cell formation via a peroxiredoxin 1 dependent pathway.

Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:3

Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; Cells, Cultured; Diterpenes; Drugs, Chinese Herbal; Foam Cells; HEK293 Cells; Humans; Lipoproteins, LDL; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Peroxiredoxins; Salvia miltiorrhiza; Signal Transduction

2018